Evidence map›Paper›PMID 34368030›Full record

ArticleFrontiers in pediatrics2021

Case Report: Changes in Cytokine Kinetics During the Course of Disease in a Japanese Patient With Multisystem Inflammatory Syndrome in Children.

Satoshi Takasago, Aiko Sakai, Masaya Sugiyama, Masashi Mizokami, Hiromichi Hamada, Yukihito Ishizaka, Tohru Miyoshi-Akiyama, Akihiro Matsunaga, Mikako Ueno, Hiroyuki Shichino and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Satoshi TakasagoDepartment of Pediatrics, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
Aiko SakaiGenome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Masaya SugiyamaGenome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Masashi MizokamiGenome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Hiromichi HamadaDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yukihito IshizakaDepartment of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Tohru Miyoshi-AkiyamaDepartment of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Akihiro MatsunagaDepartment of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Mikako UenoDepartment of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Hiroyuki ShichinoDepartment of Pediatrics, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
Ayumi MizukamiDepartment of Pediatrics, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
National Center for Global Health and Medicine · JPChiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a severe disease that is reportedly linked to coronavirus disease 2019. Affected patients present with gastrointestinal symptoms and cardiovascular dysfunction, in addition to Kawasaki disease-like features, suggesting the potential for overlapping disease mechanisms. Kawasaki disease has been reported among individuals of East Asian ethnicities, whereas there is minimal clinical literature regarding the occurrence of MIS-C among individuals of Asian ethnicities. A few reports thus far have described changes in cytokine kinetics during the course of disease in patients with MIS-C. We followed the temporal cytokine kinetics in a 9-year-old Japanese girl who exhibited a classical trajectory of MIS-C. The patient exhibited right cervical swelling and pain, abdominal pain, vomiting, and lip reddening, which developed 31 days after she was diagnosed with severe acute respiratory syndrome coronavirus-2 infection. The patient was diagnosed with Kawasaki disease on her fifth day of illness; because she fulfilled the criteria for MIS-C, she was also diagnosed with this disease on her fifth day of illness. Her fever rapidly resolved upon administration of intravenous immunoglobulin, aspirin, and prednisolone. On the patient's sixth day of illness, she developed acute myocarditis, which was treated with two diuretics and one vasodilator; the myocarditis ameliorated within a few days. Analyses of temporal kinetics for 71 serum cytokines revealed several patterns of cytokine changes that were consistent with the patient's clinical course of disease. Importantly, there was a clear distinction between cytokines that did and did not decrease rapidly following post-treatment fever resolution. These findings may be useful for the assessment of disease status and selection of therapy in patients with similar symptoms; they may also provide insights for basic and clinical research regarding MIS-C.

Indexed as

case reportCOVID-19cytokineKawasaki diseaseMIS-CPIMS-TSSARS-CoV-2

Identifiers

PMID34368030
PMCPMC8335158
OpenAlexW3186481642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.